GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Therapeutic Science Laboratories Inc (OTCPK:RTSL) » Definitions » EV-to-FCF

Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) EV-to-FCF : -15.31 (As of May. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Rapid Therapeutic Science Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Rapid Therapeutic Science Laboratories's Enterprise Value is $3.83 Mil. Rapid Therapeutic Science Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.25 Mil. Therefore, Rapid Therapeutic Science Laboratories's EV-to-FCF for today is -15.31.

The historical rank and industry rank for Rapid Therapeutic Science Laboratories's EV-to-FCF or its related term are showing as below:

RTSL' s EV-to-FCF Range Over the Past 10 Years
Min: -704.66   Med: -15.78   Max: -0.02
Current: -15.31

During the past 10 years, the highest EV-to-FCF of Rapid Therapeutic Science Laboratories was -0.02. The lowest was -704.66. And the median was -15.78.

RTSL's EV-to-FCF is ranked worse than
100% of 363 companies
in the Medical Devices & Instruments industry
Industry Median: 27.34 vs RTSL: -15.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-10), Rapid Therapeutic Science Laboratories's stock price is $0.005. Rapid Therapeutic Science Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.010. Therefore, Rapid Therapeutic Science Laboratories's PE Ratio for today is 0.50.


Rapid Therapeutic Science Laboratories EV-to-FCF Historical Data

The historical data trend for Rapid Therapeutic Science Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Therapeutic Science Laboratories EV-to-FCF Chart

Rapid Therapeutic Science Laboratories Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.02 -31.98 -320.48 -20.06 -8.11

Rapid Therapeutic Science Laboratories Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.85 -6.95 -8.11 -10.06 -17.40

Competitive Comparison of Rapid Therapeutic Science Laboratories's EV-to-FCF

For the Medical Devices subindustry, Rapid Therapeutic Science Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Therapeutic Science Laboratories's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rapid Therapeutic Science Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Rapid Therapeutic Science Laboratories's EV-to-FCF falls into.



Rapid Therapeutic Science Laboratories EV-to-FCF Calculation

Rapid Therapeutic Science Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.828/-0.25
=-15.31

Rapid Therapeutic Science Laboratories's current Enterprise Value is $3.83 Mil.
Rapid Therapeutic Science Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Therapeutic Science Laboratories  (OTCPK:RTSL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Rapid Therapeutic Science Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.005/0.010
=0.50

Rapid Therapeutic Science Laboratories's share price for today is $0.005.
Rapid Therapeutic Science Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Rapid Therapeutic Science Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Rapid Therapeutic Science Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
5580 Peterson Lane, Suite 120, Dallas, TX, USA, 75201
Rapid Therapeutic Science Laboratories Inc is a biotech company specializing in natural-based relief through aerosol delivery of cannabinoids to the systemic bloodstream through the pulmonary route of administration. The company manufactures its own branded metered dose inhalers (MDI) under the nhaler name using proprietary blends of pure cannabinoids such as cannabidiol (CBD) and cannabigerol (CBG). In addition, the company manufactures other aerosol devices for the delivery of cannabinoids other than MDI such as sublingual sprays.
Executives
Henry Anthony Punzi director 1932 WALNUT PLAZA, CARROLLTON TX 75006
Scott Suggs Justin director 639 SWORD BRIDGE DR., LEWISVILLE TX 75056
Sean Paul Berrier 10 percent owner 7108 DUFFIELD DR., DALLAS TX 75248
Schmidt Donal Ray Jr. director, 10 percent owner, officer: President and CEO 5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
Ryan Casey Johnson director, officer: Chief Operating Officer 2307 CASTLE ROCK RD, CARROLTON TX 75007
Texas Mdi, Inc. 10 percent owner 5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
D Hughes Watler director, officer: CFO 2323 S. VOSS ROAD, STE. 510-12, HOUSTON TX 77057
Steve Bond director, officer: CFO 28839 PUJOL ST., #832, TEMECULA CA 92590
Brent Willson director, officer: CEO and President 5271 CAMINITO EXQUISITO, SAN DIEGO CA 92130

Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Headlines